Insulet Corp (PODD)
259.90
+1.15
(+0.44%)
USD |
NASDAQ |
Mar 31, 13:56
Insulet Enterprise Value: 18.61B for March 28, 2025
View 4,000+ Financial Data Types:
Add
Browse
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Boston Scientific Corp | 157.07B |
| Tandem Diabetes Care Inc | 1.192B |
| Abbott Laboratories | 233.28B |
| Intuitive Surgical Inc | 171.50B |
| ResMed Inc | 32.45B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 100.70M |
| Revenue (Quarterly) | 597.50M |
| Total Expenses (Quarterly) | 488.20M |
| EPS Diluted (Quarterly) | 1.39 |
| Gross Profit Margin (Quarterly) | 72.12% |
| Profit Margin (Quarterly) | 16.85% |
| Earnings Yield | 2.23% |
| Operating Earnings Yield | 1.61% |
| Normalized Earnings Yield | 2.228 |